We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05052801
Brief Title: Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-101)

First Submitted : September 13, 2021
First Submitted that Met QC Criteria : September 13, 2021
First Posted : September 22, 2021

Last Update Submitted that Met QC Criteria : February 1, 2023
Last Update Posted : February 2, 2023